Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;3(11):1393-404.
doi: 10.3390/toxins3111393. Epub 2011 Nov 11.

Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein

Affiliations

Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein

Sergio Rondinelli et al. Toxins (Basel). 2011 Nov.

Abstract

Muscarinic toxin 7 (MT7) is a mamba venom peptide that binds selectively to the M(1) muscarinic acetylcholine receptor. We have previously shown that the second (ECL2) and third (ECL3) extracellular loops of the M(1) receptor are critically involved in binding the peptide. In this study we used a mutagenesis approach on the M(5) subtype of the receptor family to find out if this possesses a similar structural architecture in terms of toxin binding as the M(1) receptor. An M(5) receptor construct (M(5)-E(175)Y(184)E(474)), mutated at the formerly deciphered critical residues on ECL2 and 3, gained the ability to bind MT7, but with rather low affinity as determined in a functional assay (apparent K(i) = 24 nM; apparent K(i) for M(1) = 0.5 nM). After screening for different domains and residues, we found a specific residue (P(179) to L in M(5)) in the middle portion of ECL2 that was necessary for high affinity binding of MT7 (M(5)-EL(179)YE, apparent K(i) = 0.5 nM). Mutation of P(179) to A confirmed a role for the leucine side chain in the binding of MT7. Together the results reveal new binding interactions between receptors and the MT7 peptide and strengthen the hypothesis that ECL2 sequence is of utmost importance for MT binding to muscarinic receptors.

Keywords: G protein-coupled receptor; acetylcholine receptor; ligand binding; muscarinic toxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The M5 receptor and the M5-EYE mutant in Sf9 cells were assayed in the absence and presence of muscarinic toxin 7 (MT7). (a and b) Carbachol (CCh) concentration-response curves for [Ca2+]i increases. Data points are means ± SD from two experiments; (c) Amino acid sequences of extracellular loops ECL2 and ECL3. TM4-7 denotes the helical transmembrane domains of the receptors. Introduced mutations in M5 are in boldface; (d) Schematic presentation of the chimeric receptors used to localize regions of toxin binding.
Figure 2
Figure 2
Sf9 cells expressing mutated M5 receptor constructs were assayed for carbachol-induced [Ca2+]i increases and inhibition of [3H]NMS binding. (a and c) Functional analyses of the M5-ELYE and M5-EAYE receptor constructs in the absence and presence of MT7. Data points are means ± SD from two experiments. The apparent Ki values for MT7 were 0.52 ± 0.14 nM and 4.41 ± 1.09 nM (means ± SD, n = 4) for M5-ELYE and M5-EAYE, respectively; (b and d) Cell homogenates of each receptor construct were preincubated with different concentrations of MT7 before addition of 0.5 nM [3H]NMS. Bound radioactivity was converted to receptor concentration and presented as percent of control values in the absence of toxin. Data points are means ± SEM from three experiments.
Figure 3
Figure 3
Sf9 cells expressing the M5-ELY construct were assayed for carbachol-induced [Ca2+]i increases and inhibition of [3H]NMS binding. (a) Representative concentration-dependent increases in [Ca2+]i for control and in the presence of 50 nM MT7. The apparent Ki was determined to 2.06 ± 0.86 nM (mean ± SD, n = 3); (b) Titration of MT7 against [3H]NMS with M5-ELY. Data points are means ± SEM from three experiments.
Figure 4
Figure 4
Deceleration of [3H]NMS dissociation by MT7. The M5-ELY and M5-ELYE constructs were preincubated with [3H]NMS and dissociation initiated by addition of atropine with or without different concentrations of MT7. Samples were collected at different time points and [3H]NMS binding (Bt) determined. Data presented are from one experiment performed with triplicate samples. Two additional experiments with 10 and 100 nM MT7 gave similar results. Only the trendlines are shown for clarity. The control rate for M5-ELY was 0.113 min−1 and 0.003 min−1 with 100 nM MT7. The control rate for M5-ELYE was 0.147 min−1 and 0.004 min−1 with 100 nM MT7.
Figure 5
Figure 5
Reversibility test for MT7. Receptor constructs were preincubated with MT7 (30 nM with M1 and M5-ELYE, 100 nM with M5-ELY) for 45 min and then subjected to [3H]NMS binding (control (C) and zero washes) or centrifuged and washed one to three times before [3H]NMS binding. Data are means ± SEM from three experiments.

Similar articles

Cited by

References

    1. Caulfield M.P., Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998;50:279–290. - PubMed
    1. Wess J. Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Annu. Rev. Pharmacol. Toxicol. 2004;44:423–450. - PubMed
    1. Eglen R.M., Choppin A., Dillon M.P., Hegde S. Muscarinic receptor ligands and their therapeutic potential. Curr. Opin. Chem. Biol. 1999;3:426–432. - PubMed
    1. Eglen R.M., Choppin A., Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol. Sci. 2001;22:409–414. - PubMed
    1. Heinrich J.N., Butera J.A., Carrick T., Kramer A., Kowal D., Lock T., Marquis K.L., Pausch M.H., Popiolek M., Sun S.C., Tseng E., Uveges A.J., Mayer S.C. Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists. Eur. J. Pharmacol. 2009;605:53–56. - PubMed

Publication types

LinkOut - more resources